C. Roemer-Bécuwe

Everolimus as second- or third-line treatment of advanced endometrial cancer: ENDORAD, a phase II trial of GINECO

Isabelle Ray‐Coquard, Laure Favier, B. Weber et al. · British Journal of Cancer · 2013 · 102 citations · Full text

Cetuximab, topotecan and cisplatin for the treatment of advanced cervical cancer: A phase II GINECO trial

J.E. Kurtz, Anne‐Claire Hardy‐Bessard, Marion Deslandres et al. · Gynecologic Oncology · 2009 · 85 citations

Advanced Cervical Cancer, Cervical Cancer Management, Cervical Cancer +8

Prevention of 5-fluorouracil-induced early severe toxicity by pre-therapeutic dihydropyrimidine dehydrogenase deficiency screening: Assessment of a multiparametric approach

M. Boisdron‐Celle, Olivier Capitain, Roger Faroux et al. · Seminars in Oncology · 2017 · 78 citations

Preclinical Drug Evaluation, Pharmacology, Toxicology +7

When Midazolam Fails

Christine M. Cheng, C. Roemer-Bécuwe, José Pereira · Journal of Pain and Symptom Management · 2002 · 68 citations · Full text

Heart Failure, Midazolam Fails, Patient Safety +6

Phase II study of the PI3K inhibitor BKM120 in patients with advanced or recurrent endometrial carcinoma: a stratified type I–type II study from the GINECO group

Pierre-Étienne Heudel, Michel Fabbro, C. Roemer-Bécuwe et al. · British Journal of Cancer · 2017 · 64 citations · Full text